Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Alector, a privately held biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the initiation of its Phase 1 trial called INFRONT, which is evaluating AL001, the company's product candidate for the treatment of a genetically-defined sub-population of patients with frontotemporal dementia.

19 Sep 2018

Experts to present research on prevention, management of dysphagia at international conference

Over 800 delegates from 46 countries will attend the 8th annual European Society for Swallowing Disorders Congress taking place in Dublin next week to hear about new developments in swallowing disorder research.

19 Sep 2018

New study reveals mechanisms that lead to cognitive decline in Type 2 diabetes

Type 2 diabetes has been linked with an increased risk of cognitive dysfunction and dementia, but the underlying mechanisms are uncertain.

19 Sep 2018

Air pollution increases risk of dementia

A new study has shown that air pollution raises the risk of dementia. The risk remains among people of all ages find researchers.

18 Sep 2018

Research finds physical connection between the brain's fluid reservoirs and meningeal lymphatics

PureTech Health plc, an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut Axis, today notes the publication of research in Nature Neuroscience that identifies the physical connection between the brain's fluid reservoirs and the meningeal lymphatics, through which immune cells traffic out of the central nervous system.

18 Sep 2018

Amyloid β protein makes comeback as therapeutic target for Alzheimer's disease

For many years amyloid β protein was considered to be a promising therapeutic target in Alzheimer's disease but, for a long time, research results were very disappointing.

18 Sep 2018

Hospitalization after antibiotic initiation found to be higher for people with Alzheimer’s disease

Persons with Alzheimer's disease are more often hospitalized after antibiotic initiation than people without AD, a new study from the University of Eastern Finland shows.

18 Sep 2018

Lymphatic vessels surrounding the brain play crucial role in multiple sclerosis, research suggests

Lymphatic vessels that clean the brain of harmful material play a crucial role in the development and progression of multiple sclerosis, new research from the University of Virginia School of Medicine suggests.

18 Sep 2018

Element3 Health reports social and mental engagement play key role in overall health

Denver-based Element3 Health™ is coming out of stealth mode to address not one, but three critical interlocking determinants of good health - social engagement, mental stimulation and physical activity - for mature Americans.

17 Sep 2018

Researchers study if brain regions activated after negative facial stimulus are activated in people with MCI

Greek researchers investigated whether specific brain regions, which have been found to be highly activated after negative facial stimulus, are also activated in different groups of people with subjective cognitive impairment, mild cognitive impairment and Alzheimer's Disease compared to healthy controls.

17 Sep 2018

Daily low-dose aspirin does not prolong healthy life in older people, study finds

In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living (life free of dementia or persistent physical disability).

17 Sep 2018

The use of aspirin in elderly now questioned

A large study led by Australian researchers has found that taking Aspirin tablets regularly to does not really prolong life or reduce the risk of a first heart attack or stroke.

16 Sep 2018

Study could pave way for new therapies to reverse aging in human cells

Research has shed new light on genetic processes that may one day lead to the development of therapies that can slow, or even reverse, how our cells age.

14 Sep 2018

Computer avatars play role in diagnosis of dementia

Diagnosis of dementia was made via cognitive function tests such as Mini-Mental State Examination and medical imaging systems at hospitals, a fairly large system for the purpose.

14 Sep 2018

Dietary fiber may delay memory loss, brain inflammation during old age

As mammals age, immune cells in the brain known as microglia become chronically inflamed. In this state, they produce chemicals known to impair cognitive and motor function.

14 Sep 2018

New research on molecular mechanistic understanding of drug delivery and drug delivery systems

Today, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announces the publication of a new research paper "Entangled Conditional Adversarial Autoencoder for de-novo Drug Discovery" in Molecular Pharmaceutics, the leading American Chemical Society journal covering research on the molecular mechanistic understanding of drug delivery and drug delivery systems

12 Sep 2018

Penn receives NIH grant to create Center for Sub-Cellular Genomics

The five-year, $10.5 million grant from the NIH is the first CEGS awarded to Penn and funds the creation of the Center for Sub-Cellular Genomics.

12 Sep 2018

Study opens up new possibilities for designing novel medicines

A study by the Computational Biochemistry Research Group of the Universitat Jaume I of Castellón, Spain, shows that enzyme activity depends on electrostatic properties, as opposed to mechanical ones.

11 Sep 2018

Artificial anti-oxidant is up to 100 times more powerful than nature's best

Naturally-derived anti-oxidants have become the 'it' health ingredient to look for in food. But researchers from UBC Okanagan and the University of Bologna have discovered that TEMPO--a well-known artificial anti-oxidant--is up to 100 times more powerful than nature's best and could help counteract everything from skin damage to Alzheimer's Disease.

11 Sep 2018

Poorest patients in the UK will die 19 years earlier than the richest

Public Health England (PHE) has released a report on the current and future state of the nation's health in England.

11 Sep 2018

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Experts to present research on prevention, management of dysphagia at international conference

New study reveals mechanisms that lead to cognitive decline in Type 2 diabetes

Air pollution increases risk of dementia

Research finds physical connection between the brain's fluid reservoirs and meningeal lymphatics

Amyloid β protein makes comeback as therapeutic target for Alzheimer's disease

Hospitalization after antibiotic initiation found to be higher for people with Alzheimer’s disease

Lymphatic vessels surrounding the brain play crucial role in multiple sclerosis, research suggests

Element3 Health reports social and mental engagement play key role in overall health

Researchers study if brain regions activated after negative facial stimulus are activated in people with MCI

Daily low-dose aspirin does not prolong healthy life in older people, study finds

The use of aspirin in elderly now questioned

Study could pave way for new therapies to reverse aging in human cells

Computer avatars play role in diagnosis of dementia

Dietary fiber may delay memory loss, brain inflammation during old age

New research on molecular mechanistic understanding of drug delivery and drug delivery systems

Penn receives NIH grant to create Center for Sub-Cellular Genomics

Study opens up new possibilities for designing novel medicines

Artificial anti-oxidant is up to 100 times more powerful than nature's best

Poorest patients in the UK will die 19 years earlier than the richest

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in